English Archives - Page 4 of 7 - EMEA

This site provides INTERCEPT product information for International audiences .

INTERCEPT treated platelets are effective in preventing bleeding

INTERCEPT treated platelets are effective in preventing bleeding

by jaycornell | May 5, 2025

Asst. Prof. Dr. Gerda Leitner Medical University/General Hospital Vienna Vienna, Austria

Clinical performance of INTERCEPT and solvent detergent plasma used with idiopathic thrombotic purpura patients requiring therapeutic plasma exchanges

Clinical performance of INTERCEPT and solvent detergent plasma used with idiopathic thrombotic purpura patients requiring therapeutic plasma exchanges

by jaycornell | May 5, 2025

Dr. Mario Ojeda-Uribe, MD Groupe Hospitalier Region Mulhouse Sud-Alsace (GHRMSA) Hospital E. Muller Mulhouse, France

What does published literature tell us about the clinical efficacy of INTERCEPT treated platelets?

What does published literature tell us about the clinical efficacy of INTERCEPT treated platelets?

by jaycornell | May 5, 2025

Dr. Joan Cid Vidal Hospital Clínic Barcelona, Spain

Safety surveillance and the introduction of pathogen reduced platelets

Safety surveillance and the introduction of pathogen reduced platelets

by jaycornell | May 5, 2025

Dr. John Pitman, PhD Cerus Corporation Concord, USA

Ordering platelet concentrates: does pathogen inactivation matter to the clinician?

Ordering platelet concentrates: does pathogen inactivation matter to the clinician?

by jaycornell | May 5, 2025

Prof. Dr. Helmut Ostermann, LMU Kliniken University of Munich Munich, Germany

« Older Entries

Next Entries »